← Back to Search

Behavioral Intervention

Mobile Therapy for Stimulant Use Disorder in HIV (COSTA Trial)

N/A

Waitlist Available

Led By Jose Szapocznik, PhD

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 9 and 15 months.

Awards & highlights

COSTA Trial Summary

This trial tests if a mobile therapy can help treat stimulant use disorder and keep HIV viral loads suppressed in gay men with HIV.

Who is the study for?

This trial is for men living with HIV who use stimulants and aren't currently in drug treatment. They must be over 18, patients at certain clinics in Atlanta, Dallas/Fort Worth, Fort Lauderdale, or Los Angeles, not have severe psychiatric symptoms or cognitive impairment, and be less than 90% adherent to their HIV treatment.Check my eligibility

What is being tested?

The study tests if reSET—a mobile app approved by the FDA—helps men who have sex with men manage stimulant use disorder while maintaining stable HIV viral load suppression. Participants will either receive standard care or use the reSET app alongside their usual treatment.See study design

What are the potential side effects?

Since reSET is a digital therapeutic application designed to support substance abuse treatment without using medication, it does not have traditional side effects like drugs do. However, users may experience stress or frustration if they find the technology challenging.

COSTA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 9 and 15 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 9 and 15 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 9 and 15 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in days of stimulant use as measured by Timeline FollowBack

Secondary outcome measures

Proportion of subjects with viral suppression

COSTA Trial Design

2Treatment groups

Experimental Treatment

Group I: reSET GroupExperimental Treatment1 Intervention

Participants in this group will use the reSET mobile app for 12 weeks.

Group II: Standard of Care GroupExperimental Treatment1 Intervention

Participants in this group will receive standard of care treatment for 12 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,467 Previous Clinical Trials

2,618,623 Total Patients Enrolled

University of MiamiLead Sponsor

899 Previous Clinical Trials

409,182 Total Patients Enrolled

Jose Szapocznik, PhDPrincipal InvestigatorUniversity of Miami

Media Library

reSET (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05958017 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Standard of Care Group, reSET Group

Human Immunodeficiency Virus Infection Clinical Trial 2023: reSET Highlights & Side Effects. Trial Name: NCT05958017 — N/A

reSET (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05958017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this research study ongoing at present?

"As per information available on clinicaltrials.gov, this trial is no longer recruiting participants - the initial posting was made on September 1st 2023 and the last update occurred on July 14th 2023. Although it is not presently looking for volunteers, there are 467 other trials actively seeking patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

Jose Szapocznik 2024. "reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05958017.